Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-25-001805
Filing Date
2025-11-14
Accepted
2025-11-14 16:46:29
Documents
67
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q g084988_10q.htm   iXBRL 10-Q 1032411
2 EXHIBIT 31.1 g084988_ex31-1.htm EX-31.1 15182
3 EXHIBIT 31.2 g084988_ex31-2.htm EX-31.2 15269
4 EXHIBIT 32.1 g084988_ex32-1.htm EX-32.1 8024
5 EXHIBIT 32.2 g084988_ex32-2.htm EX-32.2 7893
  Complete submission text file 0001753926-25-001805.txt   4999009

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20250930.xsd EX-101.SCH 41362
7 XBRL CALCULATION FILE lipo-20250930_cal.xml EX-101.CAL 40259
8 XBRL DEFINITION FILE lipo-20250930_def.xml EX-101.DEF 129802
9 XBRL LABEL FILE lipo-20250930_lab.xml EX-101.LAB 339883
10 XBRL PRESENTATION FILE lipo-20250930_pre.xml EX-101.PRE 257738
70 EXTRACTED XBRL INSTANCE DOCUMENT g084988_10q_htm.xml XML 741439
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 251487639
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)